This article is more than 5 years old. Information may no longer be current.

Early treatment may halt progression of ocular rosacea in children

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Early treatment of ocular rosacea in children can stop the condition from progressing to vascularization and scarring, a study found.

Kendall E. Donaldson, MD, of Bascom Palmer Eye Institute, and colleagues reviewed the charts of 20 patients, aged 22 months to 17 years, who presented at a single clinic with symptoms consistent with ocular rosacea. The study is published in the January issue of Cornea.

Dr. Donaldson and colleagues found that 60% of patients improved after receiving systemic erythromycin or doxycycline and topical low-dose steroid preparations. These patients remained symptom-free at a mean 19.6 months' follow-up. Ten percent of patients did not improve despite treatment, and 30% did not have complete follow-up, the authors noted.